Revolutionising respiratory care: moveUP’s journey with DIGILUNG project
In the evolving landscape of digital health, moveUP stands out as a trailblazer in AI-driven remote patient monitoring. As a Belgian digital health company, moveUP is transforming patient care through its AI-driven platform, designed to enhance efficiency, predictability, and outcomes in rehabilitation and chronic disease management. By enabling continuous remote monitoring and data-driven treatment adjustments, healthcare professionals can make more informed decisions while reducing unnecessary physical check-ins. This allows medical experts to focus their expertise where it matters most – on delivering personalized, high-quality patient care.
Cutting-edge innovations in digital health
With extensive experience in EU projects and cutting-edge research and development (R&D), moveUP integrates digital tools into real-world clinical practice. The company is pioneering innovations such as: digital twins, computer vision, predictive modeling, large language models (LLMs) and digitally supported behavioral change inventions.
Through multiple clinical studies in digital health, moveUP has demonstrated the effectiveness of its solutions and successfully deployed its technology across Belgium, France, Germany, and the Netherlands. Notably, moveUP developed Belgium’s first mobile application to receive reimbursement approval, a groundbreaking achievement that underscores the company’s leadership in digital health.
Expanding digital health to respiratory care with DIGILUNG
As part of their commitment to advancing remote healthcare, moveUP joined the DIGILUNG project to tailor and expand their digital health solutions for respiratory diseases across Europe and the United States. This initiative represents a pivotal step in making remote monitoring more accessible and impactful for patients with chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma.
By leveraging their AI-powered platform, they aim to enhance patient outcomes through personalized care pathways that adapt to individual needs. Their technology empowers healthcare professionals to make informed decisions, reducing unnecessary in-person visits while maintaining high-quality, real-time patient monitoring.
Aligning with the European Respiratory Society’s 2025 digital transformation strategy
The European Respiratory Society (ERS) has recognised digital transformation as a key pillar in its 2025 strategy, highlighting the integration of artificial intelligence, cloud computing, and telehealth as crucial elements in the future of respiratory care. ERS aims to implement scalable and sustainable digital solutions to enhance operational efficiency and create an interconnected healthcare ecosystem. Their strategy focuses on leveraging digital tools such as machine learning, mobile applications, sensors, and wearables to provide efficient, accessible, and patient-centred respiratory care.
moveUP’s AI-powered platform aligns closely with this vision by enhancing digital health adoption in respiratory care through personalised, data-driven remote monitoring. Their work with the DIGILUNG project supports ERS’s mission by providing healthcare providers with the tools and training needed to integrate digital solutions ethically, safely, and effectively.
Driving value for investors, hospitals, and the healthcare ecosystem
moveUP stands out in the digital health sector by combining AI-powered automation, real-world evidence (RWE), and value-based care models to ensure long-term sustainability. Unlike many digital health companies struggling to find a viable business model, moveUP operates on a recurring revenue basis, partnering with life sciences companies and healthcare providers to deliver long-term clinical and economic value. With its regulatory-backed, interoperable platform spanning multiple therapeutic areas—including MSK, obesity, and respiratory care—moveUP is resilient against market fluctuations and well-positioned for continued growth.
For hospitals, moveUP’s solution helps optimise patient care, reduce hospital readmissions, and improve clinical outcomes. By enabling real-time remote monitoring, healthcare providers can detect complications early and intervene promptly, improving recovery rates while reducing unnecessary in-person visits. The platform also automates routine administrative tasks, alleviating the burden on medical staff and allowing them to focus on delivering high-priority care.
Beyond individual healthcare providers, moveUP brings immense value to the broader healthcare ecosystem by integrating predictive analytics and real-world data into clinical workflows. Patients benefit from personalised care pathways, while healthcare professionals gain data-driven decision support to enhance treatment precision. Pharmaceutical and MedTech companies leverage moveUP’s high-quality real-world evidence for regulatory submissions and treatment refinement, while payers experience cost reductions of up to 80% by preventing unnecessary procedures and hospitalisations. By aligning with value-based healthcare models, moveUP enables a more efficient, patient-centred healthcare system.
Looking ahead to 2025
The next step in moveUP’s journey is the launch of a clinical trial at a leading medical centre, which will provide robust clinical evidence for the efficacy of its respiratory care platform. This trial is a key milestone in validating the DIGILUNG solution and accelerating its expansion into global healthcare systems.
As moveUP continues to push the boundaries of digital health, the company remains committed to transforming patient care through innovation, research, and strategic collaboration.
The future of remote respiratory care is here – and moveUP is helping shape it.
The project is funded by the European Union. The expressed views and opinions belong solely to the author(s) and may not necessarily reflect the views of the European Union or EISMEA. Neither the European Union nor the funding institution can be held responsible for the expressed views.